Clinical Trial Update: AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension? [NA]

View source ↗

Summary

The trial update indicates that AIRDROP is currently recruiting to study methods to improve adherence to inhaled therapy in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pulmonary Arterial Hypertension (PAH) | NA | Status: RECRUITING